default author photo

Satoshi Teramukai

Kyoto Prefectural University of Medicine - Department of Biostatistics

Kyoto

Japan

SCHOLARLY PAPERS

3

DOWNLOADS

102

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

A Randomized Phase Ii Trial of Standard Versus Low-Dose Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Cancer: JMTO LC14-01

Number of pages: 24 Posted: 07 Apr 2022
Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Sendai Kousei Hospital - Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine, National Hospital Organization - Department of Thoracic Oncology, Osaka Police Hospital - Department of Respiratory Medicine, Otemae Hospital - Department of Pulmonary Medicine, Nagano Red Cross Hospital - Department of Pulmonary Medicine, Sendai Kousei Hospital - Department of Pulmonary Medicine, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology and The Japan-Multinational Trial Organization (JMTO)
Downloads 40 (1,196,171)

Abstract:

Loading...

Non-small cell lung cancer, nab-paclitaxel, Low dose, Phase 2

2.

Randomized Phase II Trial of Standard Versus Low-Dose Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: JMTO LC14-01

Number of pages: 34 Posted: 25 Nov 2021
Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Sendai Kousei Hospital - Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine, National Hospital Organization - Department of Thoracic Oncology, Osaka Police Hospital - Department of Respiratory Medicine, Otemae Hospital - Department of Pulmonary Medicine, Nagano Red Cross Hospital - Department of Pulmonary Medicine, Sendai Kousei Hospital - Department of Pulmonary Medicine, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology and The Japan-Multinational Trial Organization (JMTO)
Downloads 38 (1,209,354)

Abstract:

Loading...

nab-paclitaxel, optimal dose, advanced NSCLC

3.

Prediction of spread through air spaces with biopsy specimens in early-stage adenocarcinoma of the lung

Number of pages: 33 Posted: 07 May 2026
Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine - Department of Biostatistics, Kyoto Prefectural University of Medicine and Kyoto Prefectural University of Medicine
Downloads 24 (1,448,301)

Abstract:

Loading...

STAS, prediction, preoperative biopsy, Lung adenocarcinoma, histological pattern